(0.27%) 5 145.25 points
(0.17%) 38 508 points
(0.38%) 17 914 points
(-0.14%) $83.73
(0.42%) $1.931
(0.13%) $2 350.20
(0.21%) $27.59
(1.94%) $940.00
(-0.15%) $0.933
(-0.32%) $10.99
(-0.30%) $0.798
(1.28%) $93.05
Live Chart Being Loaded With Signals
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China...
Stats | |
---|---|
आज की मात्रा | 18.07M |
औसत मात्रा | 5.10M |
बाजार मूल्य | 63.00B |
EPS | HKD0 ( 2024-04-25 ) |
Last Dividend | HKD0.901 ( 2023-06-19 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 6.45 |
ATR14 | HKD0.0460 (0.23%) |
मात्रा सहसंबंध
SINOPHARM GROUP CO LTD सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
SINOPHARM GROUP CO LTD सहसंबंध - मुद्रा/वस्त्र
SINOPHARM GROUP CO LTD वित्तीय
Annual | 2023 |
राजस्व: | HKD596.57B |
सकल लाभ: | HKD48.51B (8.13 %) |
EPS: | HKD2.90 |
FY | 2023 |
राजस्व: | HKD596.57B |
सकल लाभ: | HKD48.51B (8.13 %) |
EPS: | HKD2.90 |
FY | 2022 |
राजस्व: | HKD552.15B |
सकल लाभ: | HKD47.43B (8.59 %) |
EPS: | HKD4.60 |
FY | 2021 |
राजस्व: | HKD521.05B |
सकल लाभ: | HKD44.05B (8.45 %) |
EPS: | HKD2.49 |
Financial Reports:
No articles found.
SINOPHARM GROUP CO LTD Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.901 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.0101 | 2010-04-29 |
Last Dividend | HKD0.901 | 2023-06-19 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 14 | -- |
Total Paid Out | HKD6.94 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.6 | -- |
Div. Sustainability Score | 9.69 | |
Div.Growth Potential Score | 3.37 | |
Div. Directional Score | 6.53 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
3326.HK | Ex Dividend Knight | 2023-06-07 | Annually | 0 | 0.00% | |
1553.HK | Ex Dividend Junior | 2023-06-09 | Annually | 0 | 0.00% | |
0595.HK | Ex Dividend Junior | 2023-09-06 | Annually | 0 | 0.00% | |
9616.HK | Ex Dividend Junior | 2023-08-07 | Annually | 0 | 0.00% | |
2119.HK | Ex Dividend Knight | 2023-08-30 | Semi-Annually | 0 | 0.00% | |
1120.HK | Ex Dividend Knight | 2023-06-12 | Annually | 0 | 0.00% | |
0207.HK | Ex Dividend Junior | 2023-06-12 | Sporadic | 0 | 0.00% | |
3818.HK | Ex Dividend Knight | 2023-08-21 | Annually | 0 | 0.00% | |
1709.HK | No Dividend Player | 2023-09-13 | Annually | 0 | 0.00% | |
0737.HK | Ex Dividend Knight | 2023-09-21 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0155 | 1.500 | 9.69 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0358 | 1.200 | 8.81 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.194 | 1.500 | 8.96 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.395 | 0.800 | 8.03 | 6.42 | [1 - 3] |
quickRatioTTM | 1.034 | 0.800 | 8.63 | 6.90 | [0.8 - 2.5] |
cashRatioTTM | 0.264 | 1.500 | 9.64 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.188 | -1.500 | 6.87 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 20.69 | 1.000 | 3.45 | 3.45 | [3 - 30] |
operatingCashFlowPerShareTTM | 23.49 | 2.00 | 2.17 | 4.34 | [0 - 30] |
freeCashFlowPerShareTTM | 22.23 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.965 | -1.500 | 6.14 | -9.21 | [0 - 2.5] |
grossProfitMarginTTM | 0.0838 | 1.000 | -1.937 | -1.937 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0381 | 1.000 | -1.238 | -1.238 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.017 | 1.000 | 5.46 | 5.46 | [0.2 - 2] |
assetTurnoverTTM | 2.31 | 0.800 | 10.00 | 8.00 | [0.5 - 2] |
Total Score | 9.69 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 4.31 | 1.000 | 9.67 | 0 | [1 - 100] |
returnOnEquityTTM | 0.194 | 2.50 | 9.33 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 22.23 | 2.00 | 2.59 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.75 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 23.49 | 2.00 | 2.17 | 4.34 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0825 | 1.000 | -0.437 | 0 | [0.1 - 0.5] |
Total Score | 3.37 |
SINOPHARM GROUP CO LTD
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. As of December 31, 2021, this segment had 10,259 retail pharmacies. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consultation, market information consultation and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. Sinopharm Group Co. Ltd. has a strategic partnership with I-Mab to enhance its commercial capabilities and commercialization transformation. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं